ERIS OAKNET is Productive in approach, Progressive in Spirit while being passionate to serve humanity through Price consciousness. We at Eris Oaknet practice values as being "Performance orientation", “Committed to learning”, "Integrity", “Innovation” and “Openness”. Team Eris Oaknet is Humane by being tough on eradication of ailments while being soft on affordability. ERIS OAKNET has a unique combination of a legacy business spanning over 4 decades in IPM along with an agile start up Lifesciences business thereby a powerful combination of a critical mass as well as the vibrancy and nimbleness of a new organisation. ERIS OAKNET Lifesciences was launched in April 2015 by R S Raghav and a distinguished team of professionals combining tremendous experience & expertise in varied domains, significant achievements & status amongst top 10 pharma companies in the Indian Pharmaceutical Market (IPM). The leadership team has a significant track record in scaling up business from Rs 50 crores to Rs 1500 crores and in providing significant growth opportunities to more than 2000 employees. In November 2016, team ERIS OAKNET along with a reputed PE firm with investments in varied businesses including healthcare scaled up the business by acquiring the Indian Operations of South African MNC Adcock Ingram Healthcare. The new entity thus created, Eris Oaknet Healthcare Pvt Ltd enjoys market presence of a legacy business of Cosme Farma (CFL) spanning more than four decades in such specialities as Dermatology, Gynaecology & Orthopaedics. ERIS OAKNET’s prime objective is to create a sustainable, scalable and speciality-focused Pharmaceutical organization in India. Our Exports business currently spanning across Asia and Africa regions complements our domestic operations. With more than 50 percent of our products manufactured in LL facilities with manufacturing partners who follow rigorous quality standards and are accredited by various global agencies, we have a stamp of quality.
